Steve Sosnick, Interactive Brokers’ chief strategist, discusses the latest vaccine news from Astra-Zeneca and Oxford University.
With each new vaccine development, the stock market dynamics are changing, according to Sosnick. Here’s why:
Photo Credit: Yuri Samoilov via Flickr Creative Commons
While lower costs of capital helped stocks last year and continue to do so, recent earnings calls point to the potential for lighter yields to signal trouble. As equities trade near record highs amidst rates that have drifted lower, the consideration of a worn-out consumer is pivotal.
This age cohort is becoming a powerful consumer group
Sometimes it doesn’t turn out the way they hoped.
Stock valuations are relatively high in developed markets
